poisar

Stocks · News reference

Glucotrack's Lōkahi Therapeutics Announces Expansion Of ai² Platform Into Three Divisions: ai² Pipeline, ai² Talent, And ai² Accelerator; Says Platform Now Spans 13 Universities, Has Evaluated More Than 45 Therapeutic Assets

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

GCTK
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGAR

    8-K filing — Glucotrack, Inc. (GCTK)

    Filed: 2026-09-11 AccNo: 0001493152-26-042428 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

    GCTK
  3. Benzinga Newsdesk

    Glucotrack Secures $11.5M Convertible Note Financing

    Glucotrack, Inc. (NASDAQ:GCTK) ("Glucotrack" or the "Company") today announced definitive agreements for convertible notes with an aggregate principal amount of approximately $11.5 million, including

    GCTK